The Next Phase: Exploring Innovation in Clinical Trials A Look Back: Key Learnings in Clinical Research Innovation
Aug 19, 2021
Ryan Jones, co-founder and CEO of Florence Healthcare, dives into the revolutionary changes in clinical research following the pandemic. He discusses the increased empowerment of research sites and patients through technology and emphasizes the importance of expanding diversity in trials by reaching underserved communities. Jones highlights the significance of patient engagement and autonomy in shaping future drug development. With a focus on dual expertise, he addresses the skills necessary to navigate the intersection of technology and clinical research.
AI Snips
Chapters
Transcript
Episode notes
Tech Shifts Clinical Research Focus
- Technology shifts clinical research focus from molecule discovery to patient-centered development.
- Innovations accelerate trial processes by increasing efficiency and expanding participant access.
Clinical Trials Center Shifts
- The center of clinical trial activity is shifting from pharma sponsors to sites and patients.
- Technology empowers decentralized trials and broadens access to diverse patient populations.
Tech Enables Trial Diversity
- Increasing trial diversity requires overcoming geographic and understanding barriers.
- Software enables non-traditional sites and supports patient comprehension through digital consent and ongoing dialogue.